New insights into the role of the branched-chain aminotransferase proteins in the human brain

Journal of Neuroscience Research

Volumn 93, Issue 7, 2015, Pages 987-998

  Hull, Jonathon ^a   Patel, Vinood B ^b   Hutson, Susan M ^c   Conway, Myra E ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Glutamate; HBCAT; Neurodegeneration; Neuronal toxicity; Protein folding; Redox

Indexed keywords

AMINOTRANSFERASE; BRANCHED CHAIN AMINOTRANSFERASE; GLUTAMIC ACID; UNCLASSIFIED DRUG; BRANCHED-CHAIN-AMINO-ACID TRANSAMINASE;

ALZHEIMER DISEASE; AMINO ACID METABOLISM; BRAIN; BRAIN METABOLISM; COGNITIVE DEFECT; HUMAN; HUNTINGTON CHOREA; METABOLITE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; TRANSAMINATION; TRAUMATIC BRAIN INJURY; ENZYMOLOGY; METABOLISM;

BRAIN; HUMANS; TRANSAMINASES;

EID: 84929629696     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23558     Document Type: Review

References (95)

1. Aquilani R, Iadarola P, Contardi A, Boselli M, Verri M, Pastoris O, Boschi F, Arcidiaco P, Viglio S. 2005. Branched-chain amino acids enhance the cognitive recovery of patients with severe traumatic brain injury. Arch Phys Med Rehabil 86:1729-1735.
2. Aquilani R, Boselli M, Boschi F, Viglio S, Iadarola P, Dossena M, Pastoris O, Verri M. 2008a. Branched-chain amino acids may improve recovery from a vegetative or minimally conscious state in patients with traumatic brain injury: a pilot study. Arch Phys Med Rehabil 89:1642-1647.
3. Aquilani R, Scocchi M, Iadarola P, Franciscone P, Verri M, Boschi F, Pasini E, Viglio S. 2008b. Protein supplementation may enhance the spontaneous recovery of neurological alterations in patients with ischaemic stroke. Clin Rehabil 22:1042-1050.
4. Beart PM, O'Shea RD. 2007. Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150:5-17.
5. Becker RE, Greig NH, Giacobini E. 2008. Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices? J Alzheimers Dis 15:303-325.
6. Bixel M, Shimomura Y, Hutson S, Hamprecht B. 2001. Distribution of key enzymes of branched-chain amino acid metabolism in glial and neuronal cells in culture. J Histochem Cytochem 49:407-418.
7. Brautigam CA, Wynn RM, Chuang JL. 2006. Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex. Structure 3:611-621.
8. Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS. 2003. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327-332.
9. Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS. 2005a. alpha-Keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 20:155-167.
10. Bridi R, Latini A, Braum CA, Zorzi GK, Moacir W, Lissi E, Dutra-Filho CS. 2005b. Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats. Free Radic Res 39:71-79.
11. +-independent transport exhibits metastability. J Neurochem 59:227-235.
12. Brookes N. 1993. Interaction between the glutamine cycle and the uptake of large neutral amino acids in astrocytes. J Neurochem 60:1923-1928.
13. Castellano S, Macchi F, Scali M, Huang JZ, Bozzi Y. 2006. Cytosolic branched chain aminotransferase (BCATc) mRNA is upregulated in restricted brain areas of BDNF transgenic mice. Brain Res 1108:12-18.
14. Castellano S, Casarosa S, Sweatt AJ, Hutson SM, Bozzi Y. 2007. Expression of cytosolic branched chain aminotransferase (BCATc) mRNA in the developing mouse brain. Gene Expr Patterns 7:485-490.
15. Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J. 1995. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15:711-720.
16. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
17. Chuang JL, Chuang DT. 2000. Diagnosis and mutational analysis of maple syrup urine disease using cell cultures. Methods Enzymol 324:413-423.
18. Chuang DT, Chuang JL, Wynn RM. 2006. Lessons from genetic disorders of branched-chain amino acid metabolism. J Nutr 136:243-249.
19. Cole JT, Mitala CM, Kundu S, Verma A, Elkind JA, Nissim I, Cohen AS. 2010. Dietary branched-chain amino acids ameliorate injury-induced cognitive impairment. Proc Natl Acad Sci U S A 107:366-371.
20. Cole JT, Sweatt AJ, Hutson SM. 2012. Expression of mitochondrial branched-chain aminotransferase and α-keto-acid dehydrogenase in rat brain: implications for neurotransmitter metabolism. Front Neuroanat 28:6-18.
21. Coles SJ, Easton P, Sharrod H, Hutson SM, Hancock J, Patel VB, Conway ME. 2009. S-nitrosoglutathione inactivation of the mitochondrial and cytosolic BCAT proteins: S-nitrosation and S-thiolation. Biochemistry 48:645-656.
22. Colin E, Régulier E, Perrin V, Dürr A, Brice A, Aebischer P, Déglon N, Humbert S Saudou F. 2005. Akt is altered in an animal model of Huntington's disease and in patients. Eur J Neurosci 21:1478-1488.
23. Conway ME, Yennawar N, Wallin R, Poole LB, Hutson SM. 2002. Identification of a peroxide-sensitive redox switch at the CXXC motif in the human mitochondrial branched chain aminotransferase. Biochemistry 41:9070-9078.
24. Conway ME, Yennawar N, Wallin R, Poole LB, Hutson SM. 2003. Human mitochondrial branched chain aminotransferase: structural basis for substrate specificity and role of redox active cysteines. Biochim Biophys Acta 1647:61-65.
25. Conway ME, Poole LB, Hutson SM. 2004. Roles for cysteine residues in the regulatory CXXC motif of human mitochondrial branched chain aminotransferase enzyme. Biochemistry 43:7356-7364.
26. Conway ME, Coles SJ, Islam MM, Hutson SM. 2008. Regulatory control of human cytosolic branched-chain aminotransferase by oxidation and S-glutathionylation and its interactions with redox sensitive neuronal proteins. Biochemistry 47:5465-5479.
27. Cooper AJ. 2011. 13N as a tracer for studying glutamate metabolism. Neurochem Int 59:456-464.
28. Coppus AM, Fekkes D, Verhoeven WM, Tuinier S, van Duijn CM. 2010. Plasma levels of nitric oxide related amino acids in demented subjects with Down syndrome are related to neopterin concentrations. Amino Acids 38:923-928.
29. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65:1-105.
30. Davoodi J, Drown PM, Bledsoe RK, Wallin R, Reinhart G, Hutson S. 1998. Overexpression and characterization of the human mitochondrial and cytosolic branched-chain aminotransferases. J Biol Chem 273:4982-4989.
31. El Hindy M, Hezwani M, Corry D, Hull J, El Amraoui F, Harris M, Lee C, Forshaw T, Wilson A, Mansbridge A, Hassler M, Patel VB, Kehoe PG, Love S. Conway ME. 2014. The branched-chain aminotransferase proteins: novel redox chaperones for protein disulfide isomerise: implications in Alzheimer's disease. Antioxid Redox Signal 20:2497-2513.
32. Esclaire F, Lesort M, Blanchard C, Hugon J. 1997. Glutamate toxicity enhances tau gene expression in neuronal cultures. J Neurosci Res 49:309-318.
33. Fernstrom JD. 2000. Can nutrient supplements modify brain function? Am J Clin Nutr 71:1669S-1675S.
34. Fernstrom JD, Fernstrom MH. 2007. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr 137:1539S-1547S.
35. Garcia-Espinosa MA, Wallin R, Hutson SM, Sweatt AJ. 2007. Widespread neuronal expression of branched-chain aminotransferase in the CNS: implications for leucine/glutamate metabolism and for signaling by amino acids. J Neurochem 100:1458-1468.
36. Giacobini E, Becker RE. 2007. One hundred years after the discovery of Alzheimer's disease. A turning point for therapy? J Alzheimers Dis 12:37-52.
37. Gottlieb M, Wang Y, Teichberg VI. 2003. Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 87:119-126.
38. Gueli MC, Taibi G. 2013. Alzheimer's disease: amino acid levels and brain metabolic status. Neurol Sci 34:1575-1579.
39. Hall TR, Wallin R, Reinhart GD, Hutson SM 1993. Branched-chain aminotransferase isoenzymes. Purification and characterization of the rat brain isoenzyme. J Biol Chem 268:3092-3098.
40. Hardy J. 2003. The relationship between amyloid and tau. J Mol Neurosci 20:203-206.
41. Holecek M. 2010. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 26:482-490.
42. Homanics GE, Skvorak K, Ferguson C, Watkins S, Paul HS. 2006. Production and characterization of murine models of classic and intermediate maple syrup urine disease. BMC Med Genet 31:7-33.
43. Hosoya K, Sugawara M, Asaba H, Terasaki T. 1999. Blood-brain barrier produces significant efflux of L-aspartic acid but not D-aspartic acid: in vivo evidence using the brain efflux index method. J Neurochem 73:1206-1211.
44. Hull J, Hindy ME, Kehoe PG, Chalmers K, Love S, Conway ME. 2012. Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation. J Neurochem 123:997-1009.
45. Hull J, Hindy ME, Kehoe PG, Chalmers K, Love S, Conway ME. 2015. Regional increase in the expression of the BCAT proteins in Alzheimer's disease brain- implications in glutamate toxicity. J Alzheimers Dis (in press).
46. Hutson SM. 1988. Subcellular distribution of branched-chain aminotransferase activity in rat tissues. J Nutr 118:1475-1481.
47. Hutson SM, Harper AE. 1981. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease. Am J Clin Nutr 34:173-183.
48. Hutson SM, Cree TC, Harper AE. 1978. Regulation of leucine and alpha-ketoisocaproate metabolism in skeletal muscle. J Biol Chem 253:8126-8133.
49. Hutson SM, Zapalowski C, Cree TC, Harper AE. 1980. Regulation of leucine and alpha-ketoisocaproic acid metabolism in skeletal muscle. Effects of starvation and insulin. J Biol Chem 255:2418-2426.
50. Hutson SM, Wallin R, Hall TR. 1992. Identification of mitochondrial branched chain aminotransferase and its isoforms in rat tissues. J Biol Chem 267:15681-15686.
51. Hutson SM, Berkich D, Drown P, Xu B, Aschner M, LaNoue KF. 1998. Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. J Neurochem 71:863-874.
52. Hutson SM, Lieth E, LaNoue KF. 2001. Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr 131:846S-850S.
53. Hutson SM, Poole LB, Coles S, Conway ME. 2009. Redox regulation and trapping sulfenic acid in the peroxide-sensitive human mitochondrial branched chain aminotransferase. Methods Mol Biol 476:135-148.
54. Hutson SM, Islam MM, Zaganas I. 2011. Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways. Neurochem Int 59:518-524.
55. Ichihara A, Koyama E. 1966. Transaminase of branched chain amino acids. I. Branched chain amino acids-alpha-ketoglutarate transaminase. J Biochem 59:160-169.
56. Inagaki N, Kamisaki Y, Kiyama H, Horio Y, Tohyama M, Wada H. 1987. Immunocytochemical localizations of cytosolic and mitochondrial glutamic oxaloacetic transaminase isozymes in rat primary sensory neurons as a marker for the glutamate neuronal system. Brain Res 402:197-200.
57. Islam MM, Nautiyal M, Wynn RM, Mobley JA, Chuang DT, Hutson SM. 2010. Branched-chain amino acid metabolon: interaction of glutamate dehydrogenase with the mitochondrial branched-chain aminotransferase (BCATm). J Biol Chem 285:265-276.
58. Itou M, Kawaguchi T, Taniguchi E, Oku Y, Fukushima N, Ando E, Oriishi T, Uchida Y, Otsuka M, Tanaka S, Iwasaki S, Torii M, Yoshida K, Adachi Y, Suga M, Yoshiyama M, Ibi R, Akiyama Y, Takakura M, Mitsuyama K, Tsuruta O, Sata M. 2009. Branched-chain amino acid supplements reduced ascites and increased the quality of life in a patient with liver cirrhosis: a case report. Mol Med Reports 2:977-981.
59. Jeter CB, Hergenroeder GW, Ward NH, Moore AN, Dash PK. 2013. Human mild traumatic brain injury decreases circulating branched-chain amino acids and their metabolite levels. J Neurotrauma 30:671-679.
60. Jouvet P, Kozma M, Mehmet H. 2000a. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids. Ann N Y Acad Sci 926:116-121.
61. Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, Mazarakis ND, Sarraf C, Joashi U, Kozma M, Greenwood K, Edwards AD, Mehmet H. 2000b. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919-1932.
62. 15N NMR. J Neurochem 70:1304-1315.
63. Kawaguchi T, Taniguchi E, Sata M. 2013. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. Nutr Clin Pract 28:580-588.
64. Kholodilov N, Neystat M, Oo T, Hutson S, Burke R. 2000. Upregulation of cytosolic branched chain aminotransferase in substantia nigra following developmental striatal target injury. Mol Brain Res 75:281-286.
65. Lau A, Tymianski M. 2010. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 460:525-542.
66. LaNoue KF, Berkich DA, Conway M, Barber AJ, Hu LY, Taylor C, Hutson S. 2001. Role of specific aminotransferases in de novo glutamate synthesis and redox shuttling in the retina. J Neurosci Res 66:914-922.
67. Liang Z, Valla J, Sefidvash-Hockley S, Rogers J, Li R. 2002. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem 80:807-814.
68. Lieth E, LaNoue KF, Berkich DA, Xu B, Ratz M, Taylor C, Hutson SM. 2001. Nitrogen shuttling between neurons and glial cells during glutamate synthesis. J Neurochem 76:1712-1723.
69. Lowenstein JM. 1972. Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol Rev 52:382-414.
70. Madeddu F, Naska S, Menna E, Chiellini C, Sweatt AJ, Hutson SM, Benzi L, Maffei M, Maffei L, Bozzi Y. 2004a. Intraocular delivery of BDNF following visual cortex lesion upregulates cytosolic branched chain aminotransferase (BCATc) in the rat dorsal lateral geniculate nucleus. Eur J Neurosci 20:580-586.
71. Madeddu F, Naska S, Bozzi Y. 2004b. BDNF down-regulates the caspase 3 pathway in injured geniculo-cortical neurones. Neuroreport 15:2045-2049.
72. Melone M, Bellesi M, Conti F. 2009. Synaptic localization of GLT-1a in the rat somatic sensory cortex. Glia 57:108-117.
73. Menkes JH. 1962. Maple syrup disease and other disorders of keto acid metabolism. Res Publ Assoc Res Nerv Ment Dis 40:69-93.
74. Mochel F, Charles P, Seguin F, Barritault J, Coussieu C, Perin L, Le Bouc Y, Gervais C, Carcelain G, Vassault A, Feingold J, Rabier D, Durr A. 2007. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One 2:e647.
75. Mochel F, Benaich S, Rabier D, Durr A. 2011. Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Arch Neurol 68:265-267.
76. Newgard CB. 2012. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15:606-614.
77. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD Svetkey LP. 2009. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311-326.
78. +-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier. Am J Physiol Endocrinol Metab 285:E1167-E1173.
79. +-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem 274:31891-31895.
80. +-dependent neutral amino acid transporters A, ASC, and N of the blood-brain barrier: mechanisms for neutral amino acid removal. Am J Physiol Endocrinol Metab 287:E622-E629.
81. Oldendorf WH. 1973. Stereospecificity of blood-brain barrier permeability to amino acids. Am J Physiol 224:967-969.
82. Purpera MN, Shen L, Taghavi M, Münzberg H, Martin RJ, Hutson SM, Morrison CD. 2012. Impaired branched chain amino acid metabolism alters feeding behavior and increases orexigenic neuropeptide expression in the hypothalamus. J Endocrinol 212:85-94.
83. Scarnà A, McTavish SF, Cowen PJ, Goodwin GM, Rogers RD. 2005. The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision making. Psychopharmacology 179:761-768.
84. Smith QR, Momma S, Aoyagi M, Rapoport SI. 1987. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49:1651-1658.
85. Spanaki C, Kotzamani D, Petraki Z, Drakos E, Plaitakis A. 2014. Heterogeneous cellular distribution of glutamate dehydrogenase in brain and in non-neural tissues. Neurochem Res 39:500-515.
86. Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM. 1998. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 68:72-81.
87. Sweatt AJ, Garcia-Espinosa MA, Wallin R, Hutson SM. 2004a. Branched-chain amino acids and neurotransmitter metabolism: expression of cytosolic branched-chain aminotransferase (BCATc) in the cerebellum and hippocampus. J Comp Neurol 477:360-370.
88. Sweatt AJ, Wood M, Suryawan A, Wallin R, Willingham MC, Hutson SM. 2004b. Branched-chain amino acid catabolism: unique segregation of pathway enzymes in organ systems and peripheral nerves. Am J Physiol Endocrinol Metab 286:E64-E76.
89. Treberg JR, Banh S, Pandey U, Weihrauch D. 2014. Intertissue differences for the role of glutamate dehydrogenase in metabolism. Neurochem Res 39:516-26.
90. Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J, Terasaki T. 2011. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117:333-345.
91. Vuille-Dit-Bille RN, Ha-Huy R, Stover JF. 2012. Changes in plasma phenylalanine, isoleucine, leucine, and valine are associated with significant changes in intracranial pressure and jugular venous oxygen saturation in patients with severe traumatic brain injury. Amino Acids 43:1287-1296.
92. Yudkoff M, Nissim I, Daikhin Y, Lin ZP, Nelson D, Pleasure D, Erecinska M. 1993. Brain glutamate metabolism: neuronal-astroglial relationships. Dev Neurosci 15:343-350.
93. Yudkoff M, Daikhin Y, Nissim I, Pleasure D, Stern J, Nissim I. 1994. Inhibition of astrocyte glutamine production by alpha-ketoisocaproic acid. J Neurochem 63:1508-1515.
94. Yudkoff M, Daikhin Y, Grunstein L, Nissim I, Stern J, Pleasure D, Nissim I. 1996a. Astrocyte leucine metabolism: significance of branched-chain amino acid transamination. J Neurochem 66:378-385.
95. Yudkoff M, Daikhin Y, Nelson D, Nissim I, Erecinska M. 1996b. Neuronal metabolism of branched-chain amino acids: flux through the aminotransferase pathway in synaptosomes. J Neurochem 66:2136-2145.